04/11/2025
💡 Big news from MB PHARMA! 🚀
We’re kicking off a new project focused on advanced lyophilization technology to create a stable, lyophilized form of bacteriophage lysates. This innovation will extend shelf life, simplify storage and logistics, and support large-scale production of next-generation phage therapeutics 🦠.
This project is co-funded by the European Union through the Operational Programme Technology and Application for Competitiveness (OP TAK) and the Ministry of Industry and Trade of the Czech Republic 🇪🇺🤝🇨🇿